Niaid DIR operational
Ended Awarded Last action
- Contract number
- 75N91019F00131
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,112,147
Award facts
- Opportunity
-
- N02CO7240681 Solicitation number
- Contract value 98% obligated
-
- $8,112,146.80 Current, with exercised options
- $8,300,733.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Economy Act FAR subpart 17.5
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $277,439 | |
| Funding Only Action | $2,250,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $5,584,708 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2019, with a ceiling value of $8.3 million under a cost-plus-fixed-fee pricing structure for operational support at the NIAID Directorate.
Place of performance is Frederick, MD. The order's ultimate completion date is September 12, 2020. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc., and operates as a Federally Funded Research and Development Center (FFRDC) contractor for NIH and its institutes.
In fiscal year 2020, the order generated $7 million in invoiced labor and reported one subcontractor.
Quick answers
Who was awarded contract 75N91019F00131?
75N91019F00131 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2019.
How much is contract 75N91019F00131 worth?
The government has obligated $8,112,147 on 75N91019F00131. Its potential value, with all options, is $8,300,733.
Which agency awarded contract 75N91019F00131?
National Cancer Institute (National Institutes of Health) awarded 75N91019F00131, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91019F00131 an order under another contract?
Yes. 75N91019F00131 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91019F00131 competed?
The extent of competition for 75N91019F00131 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award